ReviewBlood reviews2021

Defining the undetectable: The current landscape of minimal residual disease assessment in multiple myeloma and goals for future clarity.

Benjamin T Diamond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.